Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP625538.RAZNnnMfDuMWLYS4gWJAq-aY9bWyhF1Cf1QPvphbEjlaA130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP625538.RAZNnnMfDuMWLYS4gWJAq-aY9bWyhF1Cf1QPvphbEjlaA130_assertion type Assertion NP625538.RAZNnnMfDuMWLYS4gWJAq-aY9bWyhF1Cf1QPvphbEjlaA130_head.
- NP625538.RAZNnnMfDuMWLYS4gWJAq-aY9bWyhF1Cf1QPvphbEjlaA130_assertion description "[Analysis of PTEN, BRAF and PI3K status for determination of benefit from cetuximab therapy in metastatic colorectal cancer patients refractory to chemotherapy with wild-type KRAS.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP625538.RAZNnnMfDuMWLYS4gWJAq-aY9bWyhF1Cf1QPvphbEjlaA130_provenance.
- NP625538.RAZNnnMfDuMWLYS4gWJAq-aY9bWyhF1Cf1QPvphbEjlaA130_assertion evidence source_evidence_literature NP625538.RAZNnnMfDuMWLYS4gWJAq-aY9bWyhF1Cf1QPvphbEjlaA130_provenance.
- NP625538.RAZNnnMfDuMWLYS4gWJAq-aY9bWyhF1Cf1QPvphbEjlaA130_assertion SIO_000772 23996432 NP625538.RAZNnnMfDuMWLYS4gWJAq-aY9bWyhF1Cf1QPvphbEjlaA130_provenance.
- NP625538.RAZNnnMfDuMWLYS4gWJAq-aY9bWyhF1Cf1QPvphbEjlaA130_assertion wasDerivedFrom befree-20150227 NP625538.RAZNnnMfDuMWLYS4gWJAq-aY9bWyhF1Cf1QPvphbEjlaA130_provenance.
- NP625538.RAZNnnMfDuMWLYS4gWJAq-aY9bWyhF1Cf1QPvphbEjlaA130_assertion wasGeneratedBy ECO_0000203 NP625538.RAZNnnMfDuMWLYS4gWJAq-aY9bWyhF1Cf1QPvphbEjlaA130_provenance.